TSS
FBRX icon

Two Sigma Securities’s Forte Biosciences FBRX Stock Holding History

Two Sigma Securities’s Portfolio FBRX Stock Details FBRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-445
Closed -$7.74K – 3181
2024
Q1 		$7.74K Sell
445
-172
-28% -$3K ﹤0.01% 2796
2023
Q4 		$12.7K Buy
+617
New +$8.62K ﹤0.01% 2788
2022
Q3 		– Sell
-618
Closed -$20K – 2748
2022
Q2 		$20K Buy
+618
New +$19.6K ﹤0.01% 1956
2021
Q4 		– Sell
-774
Closed -$57K – 1700
2021
Q3 		$57K Buy
+774
New +$429K ﹤0.01% 1373
2020
Q1 		– Sell
-31
Closed -$6K – 1646
2019
Q4 		$6K Buy
+31
New +$7.02K ﹤0.01% 2281

Other funds holding FBRX

TCM
Tybourne Capital Management Hong Kong $30.9M AUM 20.1% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
CCC
Cable Car Capital San Francisco, California $289M AUM 26.33% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Two Sigma Securities's FBRX Position: Q2 2024 in Review

Two Sigma Securities sold out of Forte Biosciences (FBRX) in Q2 2024, closing a stake of 445 shares — an estimated $7.74K sold.

Two Sigma Securities first reported a position in FBRX in Q4 2019 and held it in 5 quarters. The position peaked at $57K in Q3 2021. 33 funds tracked by Wall St. Rank hold FBRX as of Q2 2024.

  • Two Sigma Securities reported no remaining Forte Biosciences position as of Q2 2024 after selling out during the quarter.
  • Two Sigma Securities sold 445 Forte Biosciences shares in Q2 2024, an estimated $7.74K.
  • Two Sigma Securities first reported a position in Forte Biosciences in Q4 2019 and held it in 5 quarters.
  • Two Sigma Securities's Forte Biosciences position peaked at $57K in Q3 2021.
  • 33 funds tracked by Wall St. Rank held Forte Biosciences as of Q2 2024.

Based on Two Sigma Securities's 13F filing for Q2 2024, filed 14 Aug 2024.